Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP3 | P05413 | 1/20 | 0.43 |
| ▸ | FABP4 | P15090 | 1/20 | 0.43 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 5/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | MAPT | P10636 | 4/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.42 |
| ▸ | SRC | P12931 | 1/20 | 0.42 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.42 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.42 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.42 |
| ▸ | TOP1 | P11387 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 5/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26199792 | 0.86 | ALDH1A1 (0.50) | FABP3FABP4FABP5MEN1KMT2A | |
| SCHEMBL895721 | 0.84 | FGFR1 (0.49) | FABP3FABP4FABP5MEN1KMT2A | |
| SCHEMBL49609 | 0.84 | FABP3 (0.44) | FABP3FABP4FABP5MEN1KMT2A | |
| SCHEMBL10868685 | 0.82 | APP (0.44) | ALDH1A1KDM4EMAPTLMNAGAA | |
| SCHEMBL12853982 | 0.81 | FGFR1 (0.49) | FABP3FABP4FABP5MEN1KMT2A | |
| Biphenyl SCHEMBL6280726 | 0.79 | FGFR1 (0.43) | FABP3FABP4FABP5MEN1KMT2A | |
| SCHEMBL13684920 | 0.79 | KDM4E (0.50) | FABP3FABP4FABP5MEN1KMT2A | |
| SCHEMBL28572577 | 0.77 | FABP3 (0.39) | FABP3FABP4FABP5MEN1KMT2A | |
| SCHEMBL355567 | 0.76 | CA1 (0.57) | FABP3FABP4FABP5MEN1KMT2A | |
| SCHEMBL27876715 | 0.76 | PDE4B (0.47) | FABP3FABP4FABP5MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090275761-A1 | Catalytic Preparation of Cyclic Carboxylic Esters | SOLVIAS AG (CH) | 2009-11-05 | — | — | US | disclosed |
| EP-1866299-A1 | CATALYTIC PREPARATION OF CYCLIC CARBOXYLIC ESTERS | Solvias AG (CH) | 2007-12-19 | — | — | EP | disclosed |
| WO-2006108802-A1 | CATALYTIC PREPARATION OF CYCLIC CARBOXYLIC ESTERS | SOLVIAS AG (CH) | 2006-10-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275761-A1 | Catalytic Preparation of Cyclic Carboxylic Esters | CA14, CA1, CA4 | FABP3 3614/4885FABP4 3554/4885FABP5 3376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.